Sign in
Taking peopleNo phase

Stopping levothyroxine after immune therapy caused an underactive thyroid in cancer patients

Tests slowly lowering levothyroxine in cancer patients with immune therapy-related hypothyroidism.

Key facts

Who runs it
Seoul National University Bundang Hospital
Where
South Korea1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
SNUH Immune Checkpoint Inhibitor-induced Hypothyroidism Recovery Trial
Status
Recruiting
People taking part
107 people, planned
Started
12 Jun 2024
Expected to end
4 Mar 2029
Type of study
Interventional
Treatments tested
  • Levothyroxine tapering
Record updated
19 February 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with cancer whose thyroid became underactive (hypothyroidism) during immune checkpoint inhibitor (ICI) treatment. They take levothyroxine and have already stopped the ICI.

Age
19 years or older
Sex
All sexes
Disease stage
Underactive thyroid (hypothyroidism) that started during ICI treatment.
Earlier treatment
Must have had ICI treatment and stopped it before joining. Must have started levothyroxine after starting the ICI.

Main reasons for not taking part

  • Took levothyroxine or anti-thyroid medicine within 3 months before starting the ICI
  • Past thyroid surgery
  • Past radioactive iodine treatment
  • Past radiation to the neck
  • Current levothyroxine dose of 0.1 mg or more

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • Adults aged 19 years or older
  • Patients with a history of treatment with immune checkpoint inhibitors (ICIs)
  • Developed hypothyroidism during ICI treatment and initiated levothyroxine after starting ICI therapy
  • Discontinued ICI therapy prior to study enrollment

Who cannot take part

  • Use of levothyroxine or antithyroid medications within 3 months prior to initiating ICI therapy
  • History of thyroid surgery, radioactive iodine therapy, or neck radiation therapy
  • Current levothyroxine dose ≥0.1 mg at the time of enrollment

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The goal of this study is to find out whether hypothyroidism caused by immune checkpoint inhibitors (ICIs) can recover after stopping the ICIs. The study also aims to identify factors that can help predict which patients will be able to stop taking thyroid hormone replacement.

Read full original descriptionShow less

The main questions the study will answer are:

* What percentage of patients recover normal thyroid function and can stop levothyroxine after stopping ICIs? * What clinical or laboratory factors can predict successful withdrawal of levothyroxine?

Participants will:

* Be adult cancer patients who developed hypothyroidism during ICI treatment and are currently taking levothyroxine * Have already stopped ICI therapy * Gradually reduce their levothyroxine dose every 3 months if their thyroid function remains normal * Stop levothyroxine if thyroid function remains normal at low doses (≤0.025 mg) * Be monitored with thyroid function tests and clinical symptoms at each visit

The group in the trial

  • Levothyroxine tapering armTreatment being tested

    Participants will undergo a gradual dose reduction of levothyroxine according to a standardized tapering protocol. The levothyroxine dose will be reduced every 3 months based on thyroid function test results. If thyroid function remains stable, the dose will be decreased by 0.025 mg (±0.0125 mg). If thyroid function remains stable at a low dose (≤0.025 mg), levothyroxine will be discontinued.

    Treatment: Levothyroxine tapering

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
SNUH Immune Checkpoint Inhibitor-induced Hypothyroidism Recovery Trial
Plain-language title
Stopping levothyroxine after immune therapy caused an underactive thyroid in cancer patientsGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
19 February 2026